EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Accelerating tacrolimus model‐informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies

Martín Umpiérrez iD, Cecilia Maldonado iD, Natalia Guevara iD, Magdalena Cardenas-Rodriguez iD, Clara Menéndez, Mariana Seija iD, José Santiago, Oscar Noboa iD, Manuel Ibarra iD

British Journal of Clinical Pharmacology · 2026-07 · 92 (7) · 2109-2126

DOI: 10.1002/bcp.70447 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 11.02.2026. Verfasst von Martín Umpiérrez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, Montevideo, Uruguay. Hauptthemen laut MEDLINE: Tacrolimus, Kidney Transplantation, Immunosuppressive Agents, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Comisión Sectorial de Investigación Científica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To guide the efficient implementation of Model‐Informed Precision Dosing (MIPD) by comparing the predictive performance of published tacrolimus population pharmacokinetic (popPK) models with an in‐house model in Uruguayan kidney transplant recipients, using comprehensive external evaluation methodology.

Methods

Twenty‐five adult tacrolimus popPK models were identified through systematic review and externally evaluated using retrospective data from 39 patients (396 steady‐state concentrations). In parallel, an in‐house model was developed with prospective and retrospective data from 49 patients (727 concentrations). Predictive performance was assessed across different data integration levels: a priori predictions and sequential Bayesian forecasting with progressive incorporation of individual observations.

Results

All published models and the in‐house model showed poor a priori predictive performance, with even the best performing models yielding MAPE values near 50% and fewer than 30% of predictions within 30% of observed concentrations. Bayesian forecasting progressively improved bias, accuracy and dispersion of prediction errors. Initial incorporation of three trough concentrations produced limited benefit, but substantial improvements were observed upon integration of a pharmacokinetic curve composed of at least 3 post‐dose concentrations, at which point several published models and the in‐house model achieved high precision, with mean bias below 10% and MAPE below 30%. Two published models exhibited comparable performance to the in‐house model, which achieved marginally better results as Bayesian forecasting incorporated successive individual observations, without providing a meaningful overall advantage.

Conclusion

Published tacrolimus popPK models can achieve clinically reliable predictions when combined with Bayesian updating, performing comparably to in‐house developed models. These findings support a resource‐efficient strategy for implementing tacrolimus MIPD without the need for local model development, provided that a pharmacokinetic curve is obtained early post‐transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusKidney TransplantationImmunosuppressive AgentsModels, BiologicalHumansBayes TheoremRetrospective StudiesAdultFemaleMaleMiddle AgedDose-Response Relationship, DrugProspective StudiesPrecision Medicine

Stichwörter der Autor:innen

Bayesian forecastingexternal evaluationmodel‐informed precision dosingtacrolimus in kidney recipients

Substanzen

TacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, Montevideo, Uruguay.
  • Molecular and Human Genetics Laboratory, Institut Pasteur de Montevideo, Montevideo, Uruguay.
  • Nephrology Center, Hospital de Clinicas Dr Manuel Quintela Faculty of Medicine, Universidad de la República, Montevideo, Uruguay.

ORCID-Profile: Martín Umpiérrez, Cecilia Maldonado, Natalia Guevara, Magdalena Cardenas-Rodriguez, Mariana Seija, Oscar Noboa, Manuel Ibarra

Förderung

  • Comisión Sectorial de Investigación Científica

Zitieren

APA

Umpiérrez, M., Maldonado, C., Guevara, N., Cardenas-Rodriguez, M., Menéndez, C., Seija, M., Santiago, J., Noboa, O., & Ibarra, M. (2026). Accelerating tacrolimus model‐informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies. British Journal of Clinical Pharmacology, 92(7), 2109-2126. https://doi.org/10.1002/bcp.70447

Vancouver

Umpiérrez M, Maldonado C, Guevara N, Cardenas-Rodriguez M, Menéndez C, Seija M, et al. Accelerating tacrolimus model‐informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies. British Journal of Clinical Pharmacology. 2026;92(7):2109-2126. doi:10.1002/bcp.70447

BibTeX
@article{Umpirrez2026,
  author = {Umpiérrez, Martín and Maldonado, Cecilia and Guevara, Natalia and Cardenas-Rodriguez, Magdalena and Menéndez, Clara and Seija, Mariana and Santiago, José and Noboa, Oscar and Ibarra, Manuel},
  title = {Accelerating tacrolimus model‐informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  volume = {92},
  number = {7},
  pages = {2109--2126},
  doi = {10.1002/bcp.70447}
}
Kostenlos starten →